160 related articles for article (PubMed ID: 3565423)
1. Effects of low potassium or magnesium concentrations on isolated cardiac tissue.
Roden DM; Iansmith DH
Am J Med; 1987 Mar; 82(3A):18-23. PubMed ID: 3565423
[TBL] [Abstract][Full Text] [Related]
2. Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium.
Davidenko JM; Cohen L; Goodrow R; Antzelevitch C
Circulation; 1989 Mar; 79(3):674-86. PubMed ID: 2917391
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and basic mechanisms of quinidine-induced arrhythmias.
Roden DM; Thompson KA; Hoffman BF; Woosley RL
J Am Coll Cardiol; 1986 Jul; 8(1 Suppl A):73A-78A. PubMed ID: 2423573
[TBL] [Abstract][Full Text] [Related]
4. Morphine suppression of digitalis-induced ventricular arrhythmias.
Rabkin SW; Einzig S; Benditt DG
Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):267-77. PubMed ID: 3426348
[TBL] [Abstract][Full Text] [Related]
5. Cellular electrophysiology of digitalis toxicity.
Rosen MR
J Am Coll Cardiol; 1985 May; 5(5 Suppl A):22A-34A. PubMed ID: 3886749
[TBL] [Abstract][Full Text] [Related]
6. Digitalis toxicity and hypomagnesemia.
Seller RH; Cangiano J; Kim KE; Mendelssohn S; Brest AN; Swartz C
Am Heart J; 1970 Jan; 79(1):57-68. PubMed ID: 5410283
[No Abstract] [Full Text] [Related]
7. Reappraisal of digitalis. X. Treatment of digitalis toxicity.
Lyon AF; DeGraff AC
Am Heart J; 1967 Jun; 73(6):835-7. PubMed ID: 4961018
[No Abstract] [Full Text] [Related]
8. [Grave ventricular arrhythmias during quinidine and digitalis therapy of chronic auricular fibrillation].
ILIESCU CC; CONSTANTINEANU M; PANTZER M
Med Interna (Bucur); 1958 Mar; 10(3):447-53. PubMed ID: 13551577
[No Abstract] [Full Text] [Related]
9. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.
Roden DM; Woosley RL; Primm RK
Am Heart J; 1986 Jun; 111(6):1088-93. PubMed ID: 3716982
[TBL] [Abstract][Full Text] [Related]
10. [Drug-induced magnesium deficiency].
Classen HG; Gröber U; Kisters K
Med Monatsschr Pharm; 2012 Aug; 35(8):274-80. PubMed ID: 22970526
[TBL] [Abstract][Full Text] [Related]
11. Diuretics, digitalis and arrhythmias.
Steiness E
Acta Med Scand Suppl; 1981; 647():75-8. PubMed ID: 6942643
[TBL] [Abstract][Full Text] [Related]
12. [Cardiac arrhythmias. I. Pathogenesis and clinical significance].
Schollmeyer P
Med Klin; 1971 Apr; 66(16):613-9. PubMed ID: 4101688
[No Abstract] [Full Text] [Related]
13. Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers.
Kaseda S; Gilmour RF; Zipes DP
Am Heart J; 1989 Sep; 118(3):458-66. PubMed ID: 2549775
[TBL] [Abstract][Full Text] [Related]
14. Early after-depolarizations and torsade de pointes: implications for the control of cardiac arrhythmias by prolonging repolarization.
Roden DM
Eur Heart J; 1993 Nov; 14 Suppl H():56-61. PubMed ID: 8293755
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced torsade de pointes.
Raehl CL; Patel AK; LeRoy M
Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
[TBL] [Abstract][Full Text] [Related]
16. Is hypomagnesemia arrhythmogenic?
Millane TA; Ward DE; Camm AJ
Clin Cardiol; 1992 Feb; 15(2):103-8. PubMed ID: 1371093
[TBL] [Abstract][Full Text] [Related]
17. Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents.
Perry RS; Illsley SS
Am J Hosp Pharm; 1986 Apr; 43(4):957-74. PubMed ID: 2871752
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiology and pharmacology of cardiac arrhythmias. VIII. Cardiac effects of diphenylhydantoin. B.
Wit AL; Rosen MR; Hoffman BF
Am Heart J; 1975 Sep; 90(3):397-404. PubMed ID: 1099889
[TBL] [Abstract][Full Text] [Related]
19. Review: Electrolyte and antiarrhythmic drug interaction.
Dreifus LS; de Azevedo IM; Watanabe Y
Am Heart J; 1974 Jul; 88(1):95-107. PubMed ID: 4152041
[No Abstract] [Full Text] [Related]
20. The pathophysiology of potassium and magnesium disturbances. A cardiac perspective.
Schipperheyn JJ
Drugs; 1984 Oct; 28 Suppl 1():112-9. PubMed ID: 6499695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
